Related Experiment Videos
Apoptosis induced by dioscin in Hela cells.
Jing Cai1, Mingjie Liu, Zhao Wang
1Department of Biological Science and Biotechnology, Tsinghua University, Beijing, China.
Biological & Pharmaceutical Bulletin
|February 21, 2002
Summary
Dioscin, a natural compound, effectively triggers apoptosis in human cervical cancer (Hela) cells. This suggests its potential as a novel therapeutic agent for cervical cancer treatment.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Cervical cancer remains a significant global health challenge.
- There is a continuous need for novel therapeutic agents.
- Natural compounds are a promising source for drug discovery.
Purpose of the Study:
- To investigate the anti-proliferative effects of Dioscin on Hela cells.
- To elucidate the mechanism of action of Dioscin-induced cell death.
- To evaluate the potential of Dioscin as a treatment for cervical cancer.
Main Methods:
- Dioscin was extracted from Polygonatum Zanlanscianense Pamp.
- Hela cells were treated with varying concentrations of Dioscin.
- Cell proliferation was assessed.
- Apoptosis was detected using caspase activity assays (caspase-3, -8, -9) and Bcl-2 expression analysis.
Main Results:
- Dioscin significantly inhibited Hela cell proliferation in a dose- and time-dependent manner.
- Dioscin induced apoptosis in Hela cells.
- Mitochondrial pathway activation was indicated by low caspase-8 and high caspase-9 activity.
- Reduced Bcl-2 expression further supported apoptosis induction.
Conclusions:
- Dioscin exhibits potent anti-cancer properties against human cervical cancer cells.
- The mechanism involves the activation of the mitochondrial apoptotic pathway.
- Dioscin represents a potential candidate for the development of new cervical cancer drugs.